Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03699319
Title CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jeffrey Hardacre

pancreatic adenocarcinoma


CPI-613 + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.